Concepedia

Aimee Jackson

AJ

Statistics

Publications

8

Citations

580

H-Index

8

Active since

2011

Affiliations

Cancer Research UK Clinical Trials Unit(Current)

University of Birmingham

Queen Elizabeth Hospital Birmingham

University of Oxford

St James's University Hospital

Aimee Jackson is an author at Cancer Research UK Clinical Trials Unit specializing in medicine, oncology, and hematology.

ORCID

Publications per year

2011–2023

8

Publications

8

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

Charles Craddock, Aimee Jackson, Justin Loke et al. · Journal of Clinical Oncology · 2020 · 165 citations · Full text

, , +14

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Claire Harrison, Jyoti Nangalia, Rebecca H. Boucher et al. · Journal of Clinical Oncology · 2023 · 142 citations · Full text

, , +8

Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)

Jennifer Pascoe, Aimee Jackson, Charlotte Gaskell et al. · BMC Cancer · 2021 · 98 citations · Full text

, , +15

Sustainability and Triple Bottom Line Reporting - What is it all about?

Aimee Jackson, Katherine Boswell, D.Y. Ebin Davis · 2011 · 66 citations

, , +14

Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS

Justin Loke, Nicholas McCarthy, Aimee Jackson et al. · Blood Advances · 2023 · 45 citations · Full text

, , +16

1–5 of 8